Culture and Functional Characterization of Human Hepatoma HepG2 Cells.

[1]  R. Jover,et al.  Hepatic cell lines for drug hepatotoxicity testing: limitations and strategies to upgrade their metabolic competence by gene engineering. , 2013, Current drug metabolism.

[2]  M. T. Donato,et al.  HepG2 cells simultaneously expressing five P450 enzymes for the screening of hepatotoxicity: identification of bioactivable drugs and the potential mechanism of toxicity involved , 2013, Archives of Toxicology.

[3]  Xiujin Li,et al.  Stable overexpression of arginase I and ornithine transcarbamylase in HepG2 cells improves its ammonia detoxification , 2012, Journal of cellular biochemistry.

[4]  Leming Shi,et al.  Similarities and Differences in the Expression of Drug-Metabolizing Enzymes between Human Hepatic Cell Lines and Primary Human Hepatocytes , 2011, Drug Metabolism and Disposition.

[5]  J. Houston,et al.  Metabolite Formation Kinetics and Intrinsic Clearance of Phenacetin, Tolbutamide, Alprazolam, and Midazolam in Adenoviral Cytochrome P450-Transfected HepG2 Cells and Comparison with Hepatocytes and In Vivo , 2010, Drug Metabolism and Disposition.

[6]  J. O'connor,et al.  Cytometric analysis for drug-induced steatosis in HepG2 cells. , 2009, Chemico-biological interactions.

[7]  Kellen L. Olszewski,et al.  Quantitative determination of urea concentrations in cell culture medium. , 2009, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[8]  L. Valenti,et al.  Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver. , 2008, The American journal of pathology.

[9]  Per Artursson,et al.  Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines , 2007, Drug Metabolism and Disposition.

[10]  G. Gores,et al.  Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity , 2007, Gut.

[11]  H. Klein,et al.  Calpain inhibition impairs glycogen syntheses in HepG2 hepatoma cells without altering insulin signaling. , 2007, The Journal of endocrinology.

[12]  José Vicente Castell,et al.  A human hepatocellular in vitro model to investigate steatosis. , 2007, Chemico-biological interactions.

[13]  B. Hirst,et al.  Predicting oral drug absorption and hepatobiliary clearance: Human intestinal and hepatic in vitro cell models. , 2006, Environmental toxicology and pharmacology.

[14]  A. Cederbaum,et al.  Adenovirus mediated overexpression of CYP2E1 increases sensitivity of HepG2 cells to acetaminophen induced cytotoxicity , 2004, Molecular and Cellular Biochemistry.

[15]  Frank Stahl,et al.  Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[16]  S. Wilkening,et al.  Influence of culture time on the expression of drug‐metabolizing enzymes in primary human hepatocytes and hepatoma cell line HepG2 , 2003, Journal of biochemical and molecular toxicology.

[17]  R. Edwards,et al.  Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells , 2002, Xenobiotica; the fate of foreign compounds in biological systems.

[18]  J. Castell,et al.  Re‐expression of C/EBPα induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells , 1998 .

[19]  J V Castell,et al.  A microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatocytes cultured on 96-well plates. , 1993, Analytical biochemistry.

[20]  R. Sormunen,et al.  Bile canaliculus formation in cultured HEPG2 cells. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[21]  N. Javitt.  Hep G2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  B. Knowles,et al.  Isolation and characterization of lipoproteins produced by human hepatoma-derived cell lines other than HepG2. , 1989, Journal of lipid research.

[23]  C C Howe,et al.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. , 1980, Science.

[24]  Ivan Damjanov,et al.  Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line , 1979, Nature.

[25]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[26]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[27]  S. Dooley,et al.  Comparative analysis of phase I and II enzyme activities in 5 hepatic cell lines identifies Huh-7 and HCC-T cells with the highest potential to study drug metabolism , 2011, Archives of Toxicology.

[28]  J V Castell,et al.  Cell lines: a tool for in vitro drug metabolism studies. , 2008, Current drug metabolism.

[29]  R. Zivin,et al.  Nile Red binding to HepG2 cells: an improved assay for in vitro studies of hepatosteatosis. , 2001, In vitro & molecular toxicology.

[30]  W. Jakoby,et al.  Assays for differentiation of glutathione S-transferases. , 1981, Methods in enzymology.